JAN (NYSE:JAN) Stock Rated Outperform in New Coverage at Mizuho

Mizuho initiated coverage on shares of JAN (NYSE:JAN) in a research report issued to clients and investors on Monday, Briefing.com reports. The firm set an “outperform” rating and a $33.00 price target on the stock. Mizuho‘s target price would suggest a potential upside of 15.63% from the company’s previous close.

A number of other research firms have also recently weighed in on JAN. Royal Bank Of Canada lifted their price target on JAN from $30.00 to $34.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Zacks Research downgraded JAN from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 20th. Weiss Ratings began coverage on JAN in a research report on Thursday, August 6th. They set a “hold (c-)” rating for the company. Huntington began coverage on JAN in a research note on Thursday, September 10th. They issued an “outperform” rating and a $36.00 price target for the company. Finally, Cantor Fitzgerald upped their price objective on shares of JAN from $30.00 to $34.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, JAN has an average rating of “Moderate Buy” and a consensus price target of $32.35.

JAN Stock Performance

JAN stock opened at $28.54 on Monday. The business has a fifty day simple moving average of $29.68 and a 200-day simple moving average of $28.02. JAN has a 52 week low of $22.76 and a 52 week high of $32.83.

JAN (NYSE:JAN) last issued its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.18). The company had revenue of $216.46 million during the quarter, compared to analysts’ expectations of $203.32 million. The business’s revenue was up 45.4% on a year-over-year basis. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. Research analysts expect that JAN will post 0.97 EPS for the current year.

Institutional Trading of JAN

Several institutional investors and hedge funds have recently added to or reduced their stakes in JAN. Nisa Investment Advisors LLC bought a new position in shares of JAN in the third quarter valued at $27,000. State of Wyoming boosted its stake in shares of JAN by 258.7% during the 3rd quarter. State of Wyoming now owns 4,814 shares of the company’s stock worth $143,000 after acquiring an additional 3,472 shares in the last quarter. Inspire Investing LLC acquired a new position in shares of JAN in the 3rd quarter worth $484,000. Greenland Capital Management LP acquired a new position in shares of JAN in the 2nd quarter worth $575,000. Finally, Sumitomo Mitsui DS Asset Management Company Ltd acquired a new stake in shares of JAN during the third quarter worth $627,000. 6.27% of the stock is owned by institutional investors and hedge funds.

JAN Company Profile

JanOne Inc (NYSE: JAN) is a social-impact and technology company focused on addressing the opioid crisis. Its activities have included the development and commercialization of solutions intended to support opioid-related treatment and prevention, with an emphasis on using business and technology to promote measurable social benefits.

Through its subsidiaries and related operations, JanOne has also pursued financial technology initiatives, including blockchain-based payment and transaction solutions.